Move Designed to Accommodate Company’s Rapid Growth

ATLANTA, October 31, 2018Oncology Analytics, a leading technology-enabled service company which provides health plans, providers and patients with an evidence-based, analytics focused approach to utilization management that is purpose-built for oncology, announced today it is expanding its operation by moving its corporate headquarters to Atlanta, Georgia.

“Atlanta is a mecca for organizations focused on cutting edge technology and breakthrough research and innovation in cancer treatments,” said Rick Dean, CEO of Oncology Analytics. “Driving the nexus of technology and patient care is fundamental to our company’s mission. We want to be part of a dynamic, forward thinking business community that shares this vision.”

Oncology Analytics provides the critical missing link for health plans in being able to manage the total cost of cancer care – which is access to current, evidence-based, disease-specific analytics on all cancer types and treatment options, backed by board-certified oncology physicians and pharmacists, to provide their members with the ability to achieve the best possible outcomes.

Founded in Plantation, FL by Dr. Marc Fishman, a hematologist, oncologist and patient advocate, Oncology Analytics will continue to retain an active presence there. The company’s new corporate headquarters will be located at 7000 Central Parkway in the vibrant Perimeter District of Atlanta, home to over 5,000 companies.

“Having our corporate headquarters in Atlanta provides us access to some of the finest clinical, technical and analytics talent in the country,” said Shay Hurst, SVP of Human Resources, Oncology Analytics. “As we look to significantly expand our team in roles focused on data science, software engineering, clinical oncology, product management and client services, we are confident Atlanta offers the resources we need for our next stage of growth.”

About Oncology Analytics
Oncology Analytics, Inc. provides health plans, providers and patients with an evidence-based, technology-driven approach to utilization management, which is purpose-built for oncology. Used by physicians to support over 3.5 million health plan members in the US and Puerto Rico, the Oncology Analytics e-Prior Authorization platform is updated daily to accurately reflect more than 6,000 oncology treatment protocols for anti-cancer treatment across all cancer types and stages, including chemotherapy, radiation therapy, precision medicine, targeted therapy, and supportive care. The company’s real-world evidence analytics is based on tens of thousands of annual chemotherapeutic cases. For more information, please visit www.oncologyanalytics.com.

Media Contacts:
Christine Boyle
Oncology Analytics, Inc.
cboyle@oncologyanalytics.com

Elyse Familant
Results Public Relations
elysef@resultspr.net